AstraZeneca

‘Covishield’ Vaccine Trial Participant Alleges Serious Side Effects, Seeks Rs 5 Cr Compensation

Chennai: In a setback to the development of COVID-19 vaccines in India, a 40-year-old man has sent a legal notice to…

November 29, 2020

COVID-19 Vaccine: Serum Institute To Apply For Emergency Authorisation In 2 Weeks

Pune: Serum Institute of India (SII) has decided to apply for emergency authorisation of COVID-19 vaccine in the next two…

November 28, 2020

COVID-19: Serum Institute Backs Vaccine’s Safety After AstraZeneca Admits Error

New Delhi: The Pune-based Serum Institute of India (SII) has said the COVID-19 vaccine developed by AstraZeneca and Oxford University…

November 27, 2020

PM Modi To Visit Serum Institute of India For Corona Vaccine Review

Pune: Prime Minister Narendra Modi will visit Pune-based Serum Institute of India (SII), which has partnered with global pharma giant…

November 26, 2020

Oxford’s COVID-19 Vaccine Produces Robust Immunity Response In Elderly: Report

London: The COVID-19 vaccine being developed by Oxford University and AstraZeneca Plc produces a robust immune response in elderly people,…

October 26, 2020

COVID-19 Vaccine: AstraZeneca Trial Volunteer Dies In Brazil

Rio De Janeiro: An AstraZeneca COVID-19 vaccine trial volunteer has died in Brazil but the trial is not being stopped,…

October 22, 2020

There Won’t Be Enough COVID-19 Vaccines Till 2024, Warns Serum Institute’s CEO

Even if a coronavirus vaccine is developed successfully by early next year, there won’t be enough to administer all global…

September 14, 2020

Good News: AstraZeneca-Oxford Resumes Vaccine Trial After A Pause

London: British pharma company AstraZeneca said on Saturday it has restarted COVID-19 vaccine trial after getting the go-ahead from the…

September 12, 2020

AstraZeneca Reveals Why Its COVID-19 Vaccine Was Halted

London: Two days after the worrying news of the clinical trials of Oxford-AstraZeneca's COVID vaccine candidate being halted, the drugmaker…

September 11, 2020

COVID Vaccine: Oxford Pause Won’t Impact Trials In India, Assures Serum Institute CEO

The clinical trials of the COVID-19 vaccine candidate being developed by Oxford University and AstraZeneca may have been put on…

September 9, 2020